Medscape Video

{{{header}}}

Many Paths, One Purpose: Cancer Survivorship Across Cultures

Experts discuss developing a cancer survivorship program to meet the needs of survivors in urban, rural, and Native American territories in western New York.

Beyond Cancer: Confronting the Challenges of Survivorship

In this series, experts from Duke Cancer Institute discuss how the integration of cancer treatment and primary care is improving patient outcomes and overcoming challenges of cancer survivorship.

Treating Obesity: Confronting a New Normal

Against a growing prevalence of obesity, recognized experts in obesity-related research, therapies, and nonmedical interventions discuss ways to address this chronic disease in clinical practice.

Life After Cancer: A New Outlook on Survivorship

In this series, developed with Stanford Medicine, experts discuss the medical, psychosocial, and educational components of care required to meet the needs of a growing population of cancer survivors.

Custom-made Cancer Therapy: Neoantigen Vaccines

Immuno-oncologists at UCSD and La Jolla Institute discuss approaches to cancer vaccines that target tumor-specific neoantigens unique to each patient's cancer, resulting in custom-made cancer therapy.

Teamwork: A Multidisciplinary Approach to Early Lung Cancer

A multidisciplinary team of NYU thoracic specialists discusses how they coordinate efforts to devise the optimal treatment plan for each of their patients with early-stage non–small cell lung cancer.

Young Adults With Type 2 Diabetes: A Journey Begins

Vanderbilt University experts discuss treatment of type 2 diabetes in young adults, examining use of new agents and devices, challenges of adherence, and risks of longer duration of disease exposure.

Better With Age: Improving Breast Cancer Care in Older Adults

Breast cancer experts at Duke and University of North Carolina discuss complexities and challenges in the treatment of older breast cancer patients, and strategies to improve their quality of life.

Alzheimer's Disease: Unraveling the Tangle

Indiana specialists discuss advances that enable earlier diagnosis of Alzheimer's disease as well as new drugs targeting cognitive changes and which patients will benefit most from approved therapies.

Setting the Course: Aligning Expectations in Multiple Sclerosis Treatment

Cleveland Clinic specialists in multiple sclerosis discuss how shared decision-making and a multidisciplinary approach work to align clinical goals with the expectations of their patients.

A Gut Reaction: The Microbiome and Immune Checkpoint Inhibitor Response

Oncologists discuss research into altering the microbiome through fecal transplant or changes in diet to improve tumor response to immune checkpoint inhibitors.

The Long Game: Extending Lung Cancer Survival

Leading thoracic oncologists at Winship Cancer Institute discuss factors that have improved lung cancer treatment and patient survival over the past decade.

Future at Risk: Treating Depression in Young Adults

Alabama mental health experts report on the urgent need to increase screening for depression in young adults and share strategies to improve early diagnosis and provide varied treatment modalities.

Invisible Threat: Prostate Cancer Without Symptoms

Prostate cancer is often asymptomatic at the time of diagnosis, and treatment can affect quality of life more than the disease itself does. In this series, specialists discuss treatment benefit vs risk.

Comorbidities in IPF: Compounding a Heavy Burden

Pulmonologists at Yale School of Medicine explain idiopathic pulmonary fibrosis (IPF); the impact of comorbidities on this incurable, progressive disease; and new directions in drug research.

Providing Equitable Care in Early Breast Cancer

Experts at Mount Sinai in New York City report on groundbreaking advances in early breast cancer therapy and discuss strategies to ensure access to comprehensive breast cancer care for all patients.

Through a Different Lens: Redefining Heart Failure

Leading cardiologists from Northwestern Medicine discuss patient challenges and treatment breakthroughs for persons diagnosed with heart failure with preserved ejection fraction.

Immune Thrombocytopenia: Protecting Endangered Platelets

University of Southern California physicians discuss challenges in diagnosis and individualized management of immune thrombocytopenia (ITP) and report on COVID vaccine precautions for these patients.

Diabetes & Kidney Disease: A Heart in Jeopardy

Top kidney and heart specialists from Indiana University School of Medicine explain how slowing the progression of chronic kidney disease can protect the heart.

An Unwelcome Return: Relapsed/Refractory Non-Hodgkin Lymphomas

Mayo Clinic oncologists discuss the importance of an accurate NHL diagnosis to inform therapy, which includes adding novel targeted agents to standard of care.

Sleepless Nation: A Public Health Epidemic

Leading sleep specialists discuss growing concerns regarding the dangers of insufficient sleep, why sleep disorders are underdiagnosed, and how to help patients get the sleep they need.

Real Progress: Tailored Therapy in Early, High-Risk Breast Cancer

Dr Lisa Carey from the University of North Carolina discusses the integration of newer therapies for high-risk, early breast cancers into clinical therapy and strategies to personalize treatment.

Bispecific Checkpoint Antibodies: A New Type of Combination Therapy

New bispecific checkpoint immunotherapies target multiple checkpoints with a single molecule, and may offer efficacy and toxicity benefits over monotherapy combination treatments.

The Other Epidemic: Type 2 Diabetes and Obesity

Leading experts discuss the increasing prevalence of type 2 diabetes in young adults, which is linked to rising rates in childhood obesity, and offer the latest strategies to slow or reverse disease progression.

Alzheimer's Disease: Hope on the Horizon

Mayo Clinic neurologists explore the devastating effects of Alzheimer's and discuss the scientific advances that led to the approval of the first new therapy for the disease in over 20 years.

Pneumonia in the Shadow of COVID-19

Leading pulmonary specialists from the University of Louisville explain the burden of community-acquired pneumonia in older adults and reflect on complications caused by COVID-19.

Beyond Glucose: Reducing CVD in Patients With Diabetes

University of California cardiologists discuss the importance of managing multiple metabolic factors in diabetes patients to slow progression of CVD. They also share risk-reduction strategies.

A Vulnerable Time: Transitioning to Adulthood With Sickle Cell Disease

Hematologists at Boston Medical Center guide patients with sickle cell disease through the transition from pediatric to adult care, including strategies to ensure medication adherence and manage pain.

Double Trouble: Lung Cancer and Coexisting COPD

COPD and lung cancer are often found in the same patient. In this series, Stanford University experts discuss the link to smoking in both diseases and COPD's effect on lung cancer treatment.

Heart Failure: Fighting for Life

Cardiologists from Stanford University Medical Center discuss management of heart failure, ranging from patients living for decades with the disease to those requiring repeat hospitalizations.

The Gift of Time: Delaying Metastasis in Prostate Cancer

Experts from Cedars-Sinai in Los Angeles explore issues faced by men with nonmetastatic castration-resistant prostate cancer and how next-generation androgen receptor inhibitors are restarting lives.

Air Supply: Targeting Eosinophils in Severe Asthma

Leading pulmonologists discuss how the identification of eosinophilic subtypes has led to improved asthma management and development of new therapies for patients with severe asthma.

A Delicate Balance: Identifying and Treating Pancreatic Cancer

Pancreatic cancer typically presents as late-stage disease, when treatment options are few. In this series, oncologists discuss how germline testing, targeted therapies, and an array of emerging treatment options are poised to improve outcomes in pancreatic cancer.

Jumping Downhill: Acute Exacerbations of IPF

UCSF pulmonologists discuss the challenge of preparing patients for acute exacerbations of IPF and the importance of early recognition of symptoms.

COVID-19: Tracking the Science

Leading epidemiologists explain how the novel coronavirus SARS-CoV-2 causes COVID-19. Virologists describe the all-out race to develop a vaccine. Physicians discuss current treatment guidelines.

Finding Balance: Updates in Treatment for Multiple Sclerosis

Neurologists pivot to virtual consults and question whether to modify standard therapies for patients with MS during the COVID-19 pandemic.

Identifying and Treating ITP

Doctors discuss the signs of immune thrombocytopenia and how the burden of this condition can affect patients and their families.

Launching From an Unstable Platform: Bipolar Depression in Adolescents and Young Adults

Toronto psychiatrists and mental health experts examine the complexities of diagnosis and treatment of bipolar depression in adolescents, and discuss important physical and psychiatric comorbidities.

Beyond the Itch: Managing and Treating Adolescent Atopic Dermatitis

Atopic dermatitis is a chronic, hereditary condition whose effect on children and adolescents extends far beyond the skin. In this series, doctors discuss strategies for managing this disease.

Defining Optimal Therapy in High-Risk Early Breast Cancer

Leading oncologists from Stanford University Medical Center report on optimal therapeutic strategies to prevent recurrence in patients with early, high-risk breast cancer.

Uncommon Malignancies: Managing Rare Non-Hodgkin Lymphomas

Oncologists from Washington University in St. Louis discuss the diagnosis of rare B-cell non-Hodgkin lymphomas as well as current treatment strategies for both indolent and aggressive subtypes.

Inroads Into Natural Killer Cell Immunotherapy

Oncologists at UCSD and MD Anderson discuss recent advances in immunotherapies using natural killer (NK) cells, including NK checkpoint inhibition and CAR NK chimeric antigen receptor (CAR) NK therapies.

Born Into Pain: Pushing for Progress in Sickle Cell Disease

Leading hematologists from Vanderbilt University discuss the diverse manifestations of sickle cell disease and strategies to manage the complex medical and psychosocial needs of patients.

Early Start: Strategies to Improve Outcomes in IPF

University of Washington pulmonologists discuss diagnostic challenges of idiopathic pulmonary fibrosis (IPF) and how early treatment and personalized management strategies can improve outcomes.

AML: The Next Generation of Tailored Therapy

In acute myeloid leukemia, identifying somatic and germline mutations allows oncologists to better individualize treatment, from targeted therapies to optimal donors for allogeneic transplant.

Cardiovascular Risk Reduction: Protecting the Aging Heart

University of Maryland cardiologists discuss the risk factors for cardiovascular disease in older patients as well as realistic goals and strategies for effective risk reduction.

Room for Optimism: Treating Metastatic NSCLC

Thoracic oncologists at the University of Colorado Cancer Center in Aurora manage patients with stage IV metastatic non-small cell lung cancer under the shadow of COVID-19.

A Persistent Problem: Preventing Heart Failure

Heart failure continues to be a leading cause of morbidity and mortality. In this series, Cardiologists discuss associated burdens of the disease and why identifying risk factors is critical to slowing the epidemic.

Small Steps in Pancreatic Cancer

MD Anderson oncologists discuss recent advances in the understanding of heritable forms of pancreatic cancer and the impact on genetic testing guidelines and screening potential for affected families.

Confronting the HIV Epidemic

Infectious disease experts from UNC Chapel Hill have developed innovative methods to engage young minority men, the fastest-growing HIV-positive population, in the prevention and treatment of HIV.

One Pill Won't Do It: Treating Chronic Pain

Pain specialists at the Cleveland Clinic discuss optimal therapies, opioid alternatives, and lifestyle alterations for treating chronic pain, which affects at least 50 million Americans.

Signal Disruption: Targeted Therapies for CLL

Hematologists from Ohio State University discuss ongoing trials and emerging developments in firstline treatment for chronic lymphocytic leukemia, including targeted and novel combination therapies.

Letting the Light Back In: New Agents for Acute Migraine Attacks

Neurologists from the Jefferson Headache Center discuss new therapeutic agents and devices that may gain control over acute migraine attacks.

Shifting the Target in Ulcerative Colitis

UCSD gastroenterologists discuss the latest developments in the diagnosis and treatment of ulcerative colitis, including the emergence of biologic therapies and new targeted small-molecule drugs.

Reducing Fracture in Postmenopausal Osteoporosis

A leading Chicago endocrinologist emphasizes the importance of early intervention to reduce postmenopausal osteoporotic fracture, including optimal pharmacologic and nonpharmacologic approaches.

Preventing Pain: Managing and Treating Rheumatoid Arthritis

UCLA rheumatologists discuss the latest therapies for rheumatoid arthritis but emphasize the key role that patients play in developing their treatment plans if the best outcomes are to be achieved.

Children With ITP: Navigating an Unpredictable Course

Hematologists at Texas Children's Hospital discuss the variable course of pediatric ITP, the burdens of chronic ITP on children and families, and management strategies of an unpredictable disorder.

Positive Strides in Triple-Negative Breast Cancer

Leading oncologists from Dana-Farber Cancer Institute and UCSF Medical Center report on recent advances in the treatment of triple-negative breast cancer, an aggressive cancer that occurs more frequently in young women.

Plaque Psoriasis: Looking for the 'Off' Switch

Increased understanding of the proinflammatory immune pathway underlying plaque psoriasis has led to the development of biologic therapies that target specific cytokines along that pathway.

Damage Control: Managing Nonalcoholic Steatohepatitis

University of California hepatologists examine the need for increased awareness of nonalcoholic steatohepatitis (NASH) and discuss key risk factors, management strategies, and emerging therapies.

Preventing Relapse: Current Strategies in MS Management

Specialists from the University of Virginia discuss the difficulties in confirming a diagnosis of multiple sclerosis as well as decision-making strategies to prevent disease progression.

New Options in Adult AML

Duke oncologists discuss expanded treatment options for older AML patients, including numerous targeted therapies and less intensive regimens that yield durable remissions and improve quality of life.

Chronic Pain: Pain Without Purpose

Specialists at the Stanford Pain Management Center examine the impact of chronic pain on health, the cycle that can convert acute to chronic pain, and strategies for the management of chronic pain.

Emerging Trends: Targeted Therapy for CLL

MD Anderson hematologists discuss recent developments in treatment options for chronic lymphocytic leukemia, including monoclonal antibodies, targeted therapies, and small-molecule inhibitors.

Start the Conversation: Genitourinary Syndrome of Menopause

Experts in reproductive science from the Women's Health Institute at Rutgers Robert Wood Johnson Medical School discuss the signs, symptoms, and treatment of genitourinary syndrome of menopause.

Chronic Heart Failure: The Myth of the Stable Patient

Cardiologists discuss persistent hospitalization rates and mortality among heart failure patients, despite treatment advances.

Slowing the Clock: Managing Type 2 Diabetes as Patients Age

Leading endocrinologists at Montefiore Medical System in New York City discuss strategies to slow progression of type 2 diabetes and manage age-related comorbidities.

Relapsed Hodgkin: A Second Chance for Success

University of Nebraska hematologists explore treatment options for relapsed/refractory Hodgkin lymphoma and discuss the importance of autologous stem cell transplantation and targeted agents.

Smoldering Multiple Myeloma: Dangerous Precursor

Revised criteria for multiple myeloma and an array of effective, well-tolerated myeloma drugs have prompted hematologists to assess the benefit of treating smoldering multiple myeloma.

Stigmatizing Movement: Strategies in Managing Tardive Dyskinesia

Movement disorder experts at Case Western Reserve University survey strategies for diagnosis of tardive dyskinesia and discuss long-term management in patients with chronic movement disorders.

Immuno-Oncology's Challenge: Overcoming Resistance

Renowned immuno-oncologists at Georgetown-Lombardi discuss the latest research into mechanisms of resistance to checkpoint inhibitors and report on promising strategies to improve anti-tumor response.

Playing the Long Game: Managing Cardiovascular Risk in Young Adults

Notable cardiologists discuss the importance of assessing risk in young adults and convey strategies for long-term risk management for the prevention of atherosclerotic cardiovascular disease.

Moving the Goal Post: Treatment-Free Remission for CML

Experts from Froedtert Hospital and the Medical College of Wisconsin discuss the new paradigm for treating chronic myeloid leukemia as a chronic disease and for assessing patient eligibility for treatment-free remission.

Making Strides: New Approaches to Metastatic Bladder Cancer

Experts from The Tisch Cancer Institute at Mount Sinai in New York City examine the complexities of treating metastatic bladder cancer and the important role that immunotherapy now plays.

Candida auris: A Resistant Fungal Infection

New Jersey infectious disease experts discuss the emerging threat of Candida auris -- the first identified multidrug-resistant fungus -- and the need for increased surveillance.

Staying Golden: Aging With HIV

San Francisco?area infectious disease experts who battled the HIV/AIDS epidemic for decades now address the unique needs and vulnerabilities of patients who are aging with HIV.

Cracking the Code: Targeted Therapies in Lung Cancer

Leading thoracic oncologists in Boston delve into the molecular targets in NSCLC and discuss current management strategies that now must take into account immunotherapy and targeted therapy options.

Extending Response: Treatment Advances in Metastatic Melanoma

Chicago oncologists use the latest immune and targeted therapies to increase survival in metastatic melanoma, and report that the microbiome may hold the key to overcoming resistance to therapy.

Boosting Platelets: Optimal Management of ITP

Hematologists from Massachusetts General Hospital examine the need for up-to-date guidance on the treatment of ITP and offer strategies to sequence medication and individualize treatment decisions.

Not the Usual Suspects: Unforeseen Risks in Osteoporosis

A University of Colorado osteoporosis specialist emphasizes the need for broader screening, especially in overlooked groups such as men, patients taking glucocorticoids, and patients with chronic kidney disease.

Hunger for Air: Management Strategies in IPF

Vanderbilt pulmonologists discuss new therapies for idiopathic pulmonary fibrosis as well as strategies to prolong life through pulmonary rehab, comorbidity management, and oxygen therapy.

Going the Distance With Metastatic Breast Cancer

Experts at Dana-Farber Cancer Institute discuss how targeted agents used in combination with endocrine therapy are extending the lives of women with HR+/HER2- metastatic breast cancer.

Extinguishing Inflammation: Evolving Challenges in IBD

Leading gastroenterologists from the University of California at San Diego delve into the warning signs for IBD and the most current strategies for diagnosing and treating these progressive diseases.

Under New Management: Approaches to Lipid Control

Cardiologists specializing in lipid management as it relates to the prevention of cardiovascular disease discuss factors that can undermine efforts to help a patient reduce cholesterol levels.

Chronic Myeloid Leukemia: Rewriting Frontline Therapy

For 20 years, TKIs have been standard treatment in CML. But a growing number of options, including generic imatinib, raises questions regarding what is optimal frontline therapy for a given patient.

Multiple Myeloma: Options for Better Outcomes

Leading oncologists from the City of Hope Medical Center discuss targeted therapies and immunotherapies, including CAR T cells, that are redefining treatment of patients with relapsed multiple myeloma.

Pressing Need: Improving Management of Chronic Constipation

Michigan gastroenterologists confront multifactorial causes of chronic constipation and discuss the varied management options, from emerging treatments to physical therapy to alternative medicine.

Lung Cancer: Immunotherapy's Expanding Indications

Oncologists at UCLA Medical Center discuss the benefits of immunotherapy alone and in combination with chemotherapy in patients with advanced lung cancer.

Non-Hodgkin Lymphoma: Test-Driving CAR T-Cell Therapy

CAR T-cell therapy is redirecting treatment and redefining the model of care for patients with relapsing lymphoma. The vanguard Moffitt team discusses the issues involved in this breakthrough therapy.

Vanishing Platelets: Issues in Thrombocytopenia

Hematologists from McMaster University in Ontario, Canada, explore the complex issues in the diagnosis and management of thrombocytopenia and ITP.

Asthma Redefined--Managing Multiple Diseases

Pittsburgh asthma experts discuss their approach to addressing the increasing prevalence of severe, adult-onset asthma.

Involuntary Movements: Managing Tardive Dyskinesia

Psychiatric experts discuss the need for early detection of tardive dyskinesia as well as decision-making regarding medication modification in the effort to prevent and manage involuntary movements.

Keeping Pace: Managing Atrial Fibrillation in Athletes

Notable cardiologists specializing in sports medicine and electrophysiology discuss strategies for treating the lifelong endurance athlete who has atrial fibrillation.

Hidden Measures: Uncovering Cardiovascular Risk

Recognized experts in cardiology and preventive medicine discuss their ongoing pursuit of optimal criteria for determining patient risk for cardiovascular disease.

Bladder Cancer: Tracking the Leaders

Unchanged for decades, the management of bladder cancer is experiencing critical advances in surgical approaches, reconstructive options, and a growing array of immunotherapies.

Diabetes and Depression: The One-Two Punch

The interplay between diabetes and depression can complicate the treatment of both conditions, requiring the coordinated efforts of physicians, mental health providers, and patients to nullify this one-two punch.

Dry Eye: A Clinical Focus

Ophthalmologists from Wills Eye Hospital report on the growing incidence of dry eye, reasons why it goes unrecognized, and best practices for diagnosis and treatment of this life-altering syndrome.

Slowing Progression: Management Strategies in COPD

Seattle pulmonary medicine specialists discuss the debilitating effect of COPD and cite how a growing understanding of the disease may improve patient outcomes.

Psoriasis in Pregnancy: Delivering Safe Outcomes

Psoriasis is a chronic autoimmune disease with an average onset age of 28 in women. Onset often coincides with pregnancy, creating discomfort as well as obstacles to treatment.

CVD and Rheumatoid Arthritis: A Dangerous Link

Leading rheumatologists at the University of Colorado discuss the need for careful screening and aggressive risk management for cardiovascular disease in patients with rheumatoid arthritis.

Women and America's HIV Epidemic

Black women in the South are disproportionately represented among new cases of HIV but face barriers to diagnosis and treatment, prompting researchers to dub the trend a silent epidemic.

Waiting to Pounce: When Varicella Returns

NYU Langone Medical Center experts discuss the complex nature of herpes zoster. Often considered straightforward, the diagnosis of herpes zoster may be overlooked and can lead to devastating sequelae.

Cholesterol, Inflammation, and Cardiovascular Risk

Cardiologists from Brigham and Women's Hospital in Boston discuss changing approaches to managing atherosclerotic cardiovascular risk in primary- and secondary-prevention cases.

Precision Nursing: Paradigm Shift in Cancer Care

In the era of precision medicine, oncology nurses are expanding their expertise into genetics and genomics, engaging in translational research, and redefining their time-honored focus on patient care.

Meningitis: Preventing a Fatal Infection

Though uncommon in the United States, meningitis can be silent and devastating. Texas infectious disease experts stay on the alert for viral and bacterial infections in high-risk groups.

Psoriatic Arthritis: An Unwanted Partnership

Experts at the University of Toronto discuss the importance of early diagnosis of psoriatic arthritis, key aspects of evaluation, and appropriate therapeutic strategies.

Hepatitis C Virus: Containing the Threat

HCV treatments are highly efficacious, but challenges remain in screening persons at risk of contracting and spreading infection, as well as in the treatment of liver diseases caused by HCV.

Breathless: When IPF Strikes

Pulmonologists discuss significant improvements being made in the diagnosis and management of idiopathic pulmonary fibrosis, a severe, chronic disease with no cause and no cure.

Personal Best: Individualizing Therapy in Melanoma

Noted oncologist Dr Jeffrey Weber details how the NYU Langone team is individualizing treatment for its metastatic melanoma patients, to allow each a personal best outcome.

Managing Bacterial Infections

Lyme disease, urinary tract infections, and gastrointestinal infections can pose clinical challenges. Experts report on key aspects in the diagnosis and treatment of these bacterial diseases.

Plan of Attack: Navigating Migraine Care

Migraine, one of the most common neurologic conditions, remains underdiagnosed and ill managed. Boston neurologists pioneer novel approaches to treat migraine.

Acute Myeloid Leukemia: Looking for Leftover Disease

A team of New York doctors is changing the course of acute myeloid leukemia by finding and killing cancer cells before the disease can clinically recur, extending remission -- and survival.

Gaining Momentum: New Strategies in Ovarian Cancer

Oncologists at MD Anderson are using innovative clinical trial design to identify effective therapies and improve outcomes in ovarian cancer.

More Than Skin Deep: Issues in Managing Atopic Dermatitis

Dermatologists at Northwestern University tackle the management of severe eczema using advanced medical and alternative treatments, and explore the intriguing relationship between eczemas and allergy.

Multiple Myeloma: A Changing Landscape

Leading oncologists from the Mayo Clinic chart the optimal course through the changing therapeutic landscape of early relapsed multiple myeloma.

Renal Cell Carcinoma: The New Challenge

Two noted oncologists tackle a puzzling clinical question: What is the optimal sequence of therapies for patients with metastatic renal cell carcinoma?

Rapid Progression: Immunotherapy in Lung Cancer

Renowned oncologists from NY-Presbyterian/Columbia University Medical Center discuss the revolutionary impact of immunotherapies for lung cancer as well as the nuances of their use in patient care.

Not on Anyone's Radar: Colorectal Cancer in Young Adults

Why is colorectal cancer on the rise in young adults? Researchers look for answers as oncologists and patients confront a cancer no one expected.

The Unsuspected Killer: Community-Acquired Pneumonia

Pneumonia can strike anyone, from presidential candidates to famous puppeteers. And the number-one cause of death from infectious disease is all too frequently a race against time.

Confronting Insulin

What is the role of insulin in the management of type 2 diabetes? A 5-part series looks at challenges for physicians and patients alike.

{{{header}}}

Tardive Dyskinesia: Implications in Mental Health Conditions

Nonhormonal Agents Effective for Menopause VMS

Targeting BCMA in Relapsed/Refractory Multiple Myeloma

Optimal Treatment of Menopause Symptoms

Lowering LDL-C in Patients Not at Goal on Statins

Factors Informing Nonhormonal Therapy of Menopause Symptoms

PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer

Evolving First-Line Treatment of Metastatic Melanoma

Evolving Use of CAR T-Cell Therapy in Large B-Cell Lymphoma

CAR T-Cell Therapy Offers Durable Responses in R/R B-ALL

New Options in Nonhormonal Therapies in Menopause

Managing the Symptom Burden of Huntington Disease

Nonhormonal Therapies for Vasomotor Symptoms of Menopause

Achieving Sustained Control of Acne Vulgaris

Combination Therapies in the Acute Treatment of Migraine

Long-Acting Contraception in Perimenopause

Achieving Long-Term Control in Plaque Psoriasis

Treatment Sequencing in Primary Biliary Cholangitis

Addressing the Symptom Burden of Primary Biliary Cholangitis

Multimechanism Approaches to Acute Migraine Treatment

Overcoming Topical Steroid Limitations in Plaque Psoriasis

Individualizing Treatment of Plaque Psoriasis

Proactive Treatment Strategies for Scalp Psoriasis

Optimizing Non-Oral Triptans in Acute Treatment of Migraine

New Treatments for Glucocorticoid-Induced Osteoporosis

Evolving Role of TKIs in Advanced EGFR-Positive NSCLC

Treating-to-Target: Osteoporosis in Postmenopausal Women

Early Diagnosis and Management of CIDP

Insights From Real-World Studies in Large B-Cell Lymphoma

Fracture Risk Management in Postmenopausal Patients

Effect of Incretin Therapies on Oral Contraceptives

Managing Kidney Disease in Patients With Type 2 Diabetes

LDL-C Lowering in High-Risk Patients

Cardiovascular Risk in Type 2 Diabetes Patients With CKD

Managing LDL Cholesterol in Clinical Practice

Addressing Elevated LDL-C With Nonstatin Therapies

Insights Into Newer Therapies for HF and CKD

Mineralocorticoid Receptor Antagonists in T2D With CKD

Treatment of Advanced RCC After TKI Monotherapy

When to Recommend CGM for Patients With Type 2 Diabetes

Use of AI for Coronary Plaque Analysis

Continuous Glucose Monitoring in Type 1 Diabetes

Significance of Ejection Fraction in Chronic Heart Failure

First-Line Treatment of Severe ANCA-Associated Vasculitis

Strategies for Controlling Severe Active AAV

New Therapies for Heart Failure: HFpEF and HFmrEF

Evolving Therapies for HFpEF Management

Use of Continuous Glucose Monitoring in Type 2 Diabetes

Use of Continuous Glucose Monitoring in Type 1 Diabetes

Treatment for Post- hospitalized HFpEF and HFmrEF Patients

{{{header}}}

Highlights in Chronic Lymphocytic Leukemia From EHA 2026

Pivotal Updates in Leukemia From ASCO 2026

Exciting Developments in Obesity Medicine from ADA 2026

Key Findings in Migraine From AHS 2026

Prostate Cancer Updates From ASCO 2026

Breakthroughs in Gastrointestinal Cancers From ASCO 2026

Key Updates in Non-Small Cell Lung Cancer From ASCO 2026

Key Findings in Multiple Myeloma From ASCO 2026

Pivotal Updates in Metastatic Breast Cancer From ASCO 2026

Key Ovarian Cancer Updates From ASCO 2026

Key Updates in Lymphoma From ASCO 2026

Key Updates in Early Breast Cancer From ASCO 2026

Highlights in Prostate Cancer From AUA 2026

Advances in Chronic Rhinosinusitis From ARS 2026

Developments in R-R Multiple Sclerosis From AAN 2026

Myasthenia Gravis Updates From AAN 2026

Updates in Ovarian Cancer From SGO 2026

Exciting Developments in Psoriasis From AAD 2026

Highlights in Atopic Dermatitis From AAD 2026

Heart Failure Updates From ACC 2026

Atherosclerosis and Lipid Management Updates From ACC 2026

Highlights in Chronic Spontaneous Urticaria From AAD 2026

Insights in Renal Cell Carcinoma From ASCO GU 2026

Disease-Modifying Therapy Updates in RRMS From ACTRIMS 2026

Highlights in Poststroke Care From ISC 2026

January 6, 2026

Highlights in ER+ Breast Cancer From SABCS 2025

December 31, 2025

Multiple Myeloma Highlights From ASH 2025

December 31, 2025

Advances in PNH From ASH 2025

December 30, 2025

Chronic Lymphocytic Leukemia Highlights From ASH 2025

December 30, 2025

Chronic Myeloid Leukemia Highlights From ASH 2025

December 30, 2025

New Options in Follicular Lymphoma From ASH 2025

December 3, 2025

Updates on Treatment Options for Urticaria From ACAAI 2025

December 2, 2025

Advances in Glomerular Diseases From ASN 2025

November 24, 2025

Key Updates in Myasthenia Gravis From AANEM 2025

October 17, 2025

Key Updates in RRMS From ECTRIMS 2025

August 22, 2025

Advances in Neovascular Macular Degeneration From ASRS 2025

Key Updates in AxSpA From EULAR 2025

Prostate Cancer Highlights From ASCO 2025

Metastatic Breast Cancer Highlights From ASCO 2025

Early Breast Cancer Highlights From ASCO 2025

Clinical Advances in Multiple Myeloma From ASCO 2025

Lymphoma Highlights From ASCO 2025

Updates in Metastatic NSCLC From ASCO 2025

Key Abstracts in Early-Stage NSCLC From ASCO 2025

Key Highlights in Ovarian Cancer From ASCO 2025

Prostate Cancer Highlights From AUA 2025

Highlights in Myasthenia Gravis From AAN 2025

Key Updates in RRMS From AAN 2025

Key Advances in Hypertension From ACC 2025

HS Highlights From the AAD 2025 Annual Meeting

{{{header}}}

Obesity Management After Unsuccessful Dieting

Differential Diagnosis of Suspected Pulmonary Fibrosis and Efficacy of Approved Therapies

Adult With Established RA and Symptoms of ILD/PPF

February 10, 2026

Endometrial Cancer e-Tumor Boards: Case 6: De-Differentiated Endometrial Cancer

February 10, 2026

Endometrial Cancer e-Tumor Boards: Case 5: Multiply Recurrent Stage II Endometrial Cancer

September 16, 2025

NSCLC e-Tumor Boards: Case 9: Oligometastatic Lung Cancer

September 16, 2025

NSCLC e-Tumor Boards: Case 8: Resectable NSCLC With Comorbid Rheumatoid Arthritis

September 16, 2025

NSCLC e-Tumor Boards: Case 7: Stage III Unresectable NSCLC

Bladder Cancer e-Tumor Boards: Case 9: Metastatic Recurrent Urothelial Cancer

Bladder Cancer e-Tumor Boards: Case 8: Localized Muscle Invasive Bladder Cancer

Bladder Cancer e-Tumor Boards: Case 7: Multifocal Muscle Invasive Bladder Cancer

December 2, 2024

CML e-Tumor Boards: Case 4: CML Diagnosed During Pregnancy

November 20, 2024

CML e-Tumor Boards: Case 3: Treatment Free Remission

November 12, 2024

CML e-Tumor Boards: Case 2: ETLS Low-Risk CML

October 16, 2024

RCC e-Tumor Boards: Case 8: Refractory Renal Cell Carcinoma

October 16, 2024

RCC e-Tumor Boards: Case 7: RCC with Fibromyomatous Stroma

September 5, 2024

Breast Cancer e-Tumor Boards: Case 6: ER+ mBC with BRAF V600E Mutation

August 30, 2024

Breast Cancer e-Tumor Boards: Case 5: Metastatic High-Grade Neuroendocrine Carcinoma

August 19, 2024

CML e-Tumor Boards: Case 1: Newly Diagnosed Low-Risk CML

Breast Cancer e-Tumor Boards: Case 4: ER+ mBC with Multiple Targetable Mutations

Preventing Future Osteoporotic Fragility Fractures

Endometrial Cancer e-Tumor Boards: Case 4: Advanced Endometrial Cancer

Endometrial Cancer e-Tumor Boards: Case 3: FIGO Stage I Endometrial Cancer with Recurrence

Prostate Cancer e-Tumor Boards: Case 6: Local Recurrent PSMA-Negative Prostate Cancer

Biliary Tract Cancer e-Tumor Boards: Case 2: Locally Advanced Intrahepatic Cholangiocarcinoma

Biliary Tract Cancer e-Tumor Boards: Case 1: Hilar Cholangiocarcinoma Bile Duct Cancer

Heart Failure With Preserved Ejection Fraction

January 2, 2024

Triple Negative Breast Cancer e-Tumor Boards: Case 3: PD-L1 Negative TNBC with Homologous Recombination Deficiency

December 8, 2023

Gastric Cancer e-Tumor Boards: Case 4: Superficial Adenocarcinoma

December 5, 2023

Gastric Cancer e-Tumor Boards: Case 3: Moderately Differentiated Adenocarcinoma with Pelvic Metastasis

November 30, 2023

Gastric Cancer e-Tumor Boards: Case 2: Gastroesophageal Junction Adenocarcinoma

November 30, 2023

Gastric Cancer e-Tumor Boards: Case 1: Signet Ring Cell Adenocarcinoma with CDH1 Mutation

November 9, 2023

Ovarian Cancer e-Tumor Boards: Case 5: High-Grade Serous Ovarian Carcinoma with BRCA Mutation

November 8, 2023

Pancreatic Cancer e-Tumor Boards: Case 1: Localized Pancreatic Cancer

November 2, 2023

Ovarian Cancer e-Tumor Boards: Case 4: Ovarian Germ Cell Tumor

October 27, 2023

Ovarian Cancer e-Tumor Boards: Case 3: Clear Cell Carcinoma, Adenofibroma and Borderline Tumor

October 18, 2023

Ovarian Cancer e-Tumor Boards: Case 2: Stage IV High Grade Serous Carcinoma with Isolated Recurrence

October 18, 2023

Ovarian Cancer e-Tumor Boards: Case 1: Metastatic High-Grade Serous Carcinoma

September 15, 2023

Lymphoma e-Tumor Boards: Case 1: Recurrent Classic Hodgkin Lymphoma

September 8, 2023

Cervical Cancer e-Tumor Boards: Case 2: Advanced Stage Recurrent Cervical Cancer

September 8, 2023

Cervical Cancer e-Tumor Boards: Case 1: Cervical Adenosquamous Carcinoma

September 1, 2023

MSK Pediatrics e-Tumor Boards: Case 3: Pediatric Erdheim-Chester Disease

September 1, 2023

MSK Pediatrics e-Tumor Boards: Case 2: Multisystem Rosai-Dorfman Disease

August 22, 2023

RCC e-Tumor Boards: Case 6: Hereditary Non-Clear Cell RCC

August 21, 2023

MSK Pediatrics e-Tumor Boards: Case 1: Chemotherapy-refractory Langerhans Cell Histiocytosis (LCH) with BRAF V600E Mutation

August 15, 2023

RCC e-Tumor Boards: Case 5: Metastatic Recurrence of High-Grade Clear Cell RCC

August 15, 2023

Bladder Cancer e-Tumor Boards: Case 6: Variant Histology, Clinically Node-Positive Bladder Cancer

RCC e-Tumor Boards: Case 4: Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma

Triple Negative Breast Cancer e-Tumor Boards: Case 2: Stage IV TNBC with Multiple Mutations

Bladder Cancer e-Tumor Boards: Case 5: High Grade Invasive Bladder Cancer

{{{header}}}

AHS 2026: Applying Expectation and New Agents in Migraine

Translating ASCO 2026 Into Practice in mBC

ASCO 2026: Redefining First-Line Therapy in HER2+ GEA

ASCO 2026: Practice-Changing Strategies in Prostate Cancer

ASCO 2026: Advancing Precision Care in Early Breast Cancer

ASCO 2026: Impact of Targeted Approaches in Advanced NSCLC

ASCO 2026: Applying New TKI Data and Risk Markers in CML

ASCO 2026: Clinical Impact of Updates in Gynecologic Cancers

AHS 2026: New Pathways Redefining Migraine Care

ASCO 2026: Advances in CML Treatment

ASCO 2026: Key Highlights in Endometrial and Cervical Cancer

ASCO 2026: Key Therapeutic Trials in Prostate Cancer

ASCO 2026: Evolving Adjuvant Therapy in Early Breast Cancer

ASCO 2026: Emerging Treatment Strategies in Advanced NSCLC

ASCO 2026 Highlights: Gastroesophageal, Gastric, and GIST

ASCO 2026: Emerging Targeted and ADC Strategies in mBC

AUA 2026: PSA and PFS in Metastatic Prostate Cancer

Discussing a Diagnosis of Alzheimer’s Disease With Patients

Conference MDAngle: AHS 2026 Migraine Treatment

AHS 2026: Anticipating Key Advances in Migraine Treatment

Conference MDAngle: ASCO 2026 Gastrointestinal Cancers

ASCO 2026 Preview: Advances in GI Cancers

AUA 2026: Key Updates in Metastatic Prostate Cancer

Conference MDAngle: ASCO 2026 Prostate Cancer

ASCO 2026: Anticipating New Data in Prostate Cancer

Conference MDAngle: ASCO 2026 Gynecologic Cancers: Cervical and Endometrial

ASCO 2026: Previewing Cervical and Endometrial Cancer Data

Beyond Hot Flash: Shared Decision-Making in Menopause

Conference MDAngle: ASCO 2026 Chronic Myeloid Leukemia

ASCO 2026: A Glimpse of Key CML Treatment Updates

Addressing Patient Concerns About Vitiligo

Conference MDAngle: ASCO 2026 Advanced NSCLC

ASCO 2026: Previewing Updates in Advanced NSCLC

Conference MDAngle: ASCO 2026 Early Breast Cancer

Anticipating Key Early Breast Cancer Research at ASCO 2026

Conference MDAngle: ASCO 2026 Metastatic Breast Cancer

ASCO 2026: Previewing Updates on ADCs and SERDs in mBC

AAN 2026: Reflections on a New Era in Myasthenia Gravis

Conference MDAngle: AUA 2026 Metastatic Prostate Cancer

AUA 2026: Previewing Metastatic Prostate Cancer Updates

AAN 2026: Future Directions in RRMS Management

Practice-Changing Ovarian Cancer Updates From SGO 2026

AAN 2026: Redefining Success in Myasthenia Gravis

AAN 2026: Key RRMS Clinical Trial Updates

AAD 2026: Redefining CSU Management

SGO 2026: Ovarian OS Gains and New Endometrial Targets

AAD 2026: Integrating Weight Management into Psoriasis Care

ACC 2026: ATTR-CM Advances Extend Survival and Function

Conference MDAngle: AAN 2026 Myasthenia Gravis

AAN 2026: Exploring New Terrain in Myasthenia Gravis Care

{{{header}}}

Help Patients Break Bad Sleep Habits and Ditch Sleep Aids

Married to Medicine: Running a Joint Oncology Clinic

How Income Disparity Drives Cancer Trial Gaps

Can We Trust the Medical Literature?

Avoid These Legal Pitfalls When Using AI Scribes

The Future of Continuous Ketone Monitoring

PsA Rx Pipeline and Practice: What Clinicians Need to Know

Practice-Changing Data in GI Oncology

Can AI Save Doctors From Missed Diagnoses?

AI in Psychiatry: What's Ready and What's Not

Nasal Strips: Fancy Tape or Medical Miracle?

The Massive Clinical Payoff of Full Lung Screening

Are Cancer Guidelines Hemming In Creativity?

The Day After Residency, I Opened My Own Practice

New Guidelines for Managing Metastatic Uveal Melanoma

New Guidance on the Pharmacologic Treatment of Obesity

Recognizing the Cardiometabolic Impact of Psoriasis

The COVID Vaccine Study the CDC Doesn’t Want You to See

Athletes Competing While Injured: Who Decides?

High Blood Pressure? Consider the Aldosterone Connection

{{{header}}}

CMV: Focus on Clinician and Patient Awareness

September 24, 2021

Prevent VTE TV – The Latest Clinical Updates

September 29, 2020

CGM-TV: Best Practices and Case Consults in Pediatric (T1D) and Adult (T2D) Patients

CME TV: Prevent VTE TV

December 19, 2019

Meningitis TV – Prevention Strategies in the Modern Era

Heart Failure TV: Managing Heart Failure in the Community

Functional GI Disorders TV: IBS-C, CIC, and IBS-D

October 30, 2018

Diagnosis TV: Timely Identification, Informed Patient Care in Infectious Diseases

CME TV: Contemporary Topics in Pulmonary Hypertension

Thrombosis TV: Treatment Across the Spectrum of Thromboembolic Disease

February 28, 2017

HPV-TV: Protection Today Against Cancer Tomorrow

September 20, 2016

Insulin TV: Individualized Management of Type 2 Diabetes

HIV-TV: Best Practices Along the Care Continuum

October 29, 2015

VTE TV: The Real Clinicians of VTE

Diabetes TV: Modern T2 Diabetes TV

PH TV Season 2: Focus on Expanding Care Options and Approaches

October 14, 2011

PainTV: Chronic Pain in America

{{{header}}}

Challenges and Opportunities in Introducing Novel Therapies for the Treatment of Epidermolysis Bullosa

The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease

Precision Meets Collaboration: Advancing Personalized Multidisciplinary Care for mHSPC

Clinical Trials in CLL and MCL: Expert In-Depth Analysis

December 31, 2024

Inflammation in Dry Eye Disease

December 3, 2024

Myeloma Expert Q&A: Evolving Strategies in Newly Diagnosed MM and Early-Line Therapy

November 25, 2024

Differential Diagnosis of Pediatric Cholestatic Liver Diseases

November 22, 2024

Improving the Timely and Equitable Diagnosis of Multiple Sclerosis

November 20, 2024

The Immunotherapy Mosaic in NSCLC: Pioneering Treatment Frontiers From Early to Advanced Stages

November 14, 2024

Clinical Pearls for Cardiac Surgery-Related Complications: Key Perspectives on Managing Acute Kidney Injury

November 1, 2024

Advances in Heart Failure: Data-Driven Insights and Clinical Implications for Nonsteroidal MRAs

October 30, 2024

Precision in Diagnosing Coronary Artery Disease: When Precise Testing Leads to Better Results

October 25, 2024

Case Series: Defining the Role of Immunotherapy Across Melanoma Care

October 24, 2024

Reflux Is Everywhere: A Primary Care Guide to Managing Gastroesophageal Reflux Disease

October 22, 2024

A Breath of Change in Bronchiectasis: Exploring New Therapies and Patient Perspectives

October 14, 2024

A Case From the Real World: Treating Advanced Melanoma as Part of the Interdisciplinary Team

September 25, 2024

Latest Clinical Considerations for the Non-Transfusion-Dependent Thalassemias

September 17, 2024

Expert Insights on New Data for Severely Elevated Triglycerides

September 13, 2024

Interprofessional Approaches to Managing Adverse Events in EGFR-Mutated NSCLC

August 29, 2024

Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting